Clinical Practice Guidelines Developed for Pediatric Obesity

Share this content:
Clinical Practice Guidelines Developed for Pediatric Obesity
Clinical Practice Guidelines Developed for Pediatric Obesity

MONDAY, Feb. 6, 2017 (HealthDay News) -- In a clinical practice guideline published online Jan. 31 in the Journal of Clinical Endocrinology and Metabolism, recommendations are presented for the assessment, treatment, and prevention of pediatric obesity.

Dennis M. Styne, M.D., from the University of California Davis in Sacramento, and colleagues reviewed the literature and used available evidence to formulate guidelines relating to pediatric obesity.

The authors note that endocrine etiologies are rarely seen for obesity, and are generally accompanied by attenuated growth patterns. Screening for comorbidities should be conducted for early identification. Only in the presence of specific historical or physical features is genetic screening for rare syndromes indicated. Screening for mental health issues and counseling as indicated is necessary due to the psychological burden of pediatric obesity. Promoting healthful diet, activity, and environment should be a primary goal for prevention of pediatric obesity. Weight-loss medications should be restricted to clinical trials; bariatric surgery is effective in the most seriously affected mature teenagers with failed lifestyle modification.

"Intensive, family-centered lifestyle modifications to encourage healthy diet and activity remain the central approach to preventing and treating obesity in children and teenagers," Styne said in a statement.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC Issues Warning on Contaminated Raw Milk

CDC Issues Warning on Contaminated Raw Milk

Case of New Jersey woman becoming ill after drinking raw milk from Udder Milk company

Cerebral Morphometric Changes Discriminate ADHD, Controls

Cerebral Morphometric Changes Discriminate ADHD, Controls

Alterations discern ADHD-I, ADHD-C, with discriminating features located in DMN, insular cortex

Baby Boomers Have Increased Risk of Rx Opioid Overdose Death

Baby Boomers Have Increased Risk of Rx Opioid ...

In addition, those born from 1947 to 1964 and 1979 to 1992 have increased risk of heroin overdose death

is free, fast, and customized just for you!

Already a member?

Sign In Now »